ライフサイエンスコーパス: mucosa

1 primary colorectal tumors and matched normal mucosa.

2 patients with UC than healthy and resolving mucosa.

3 crease in IL-17C expression in human gastric mucosa.

4 f Ly6C(+) monocytes from blood to intestinal mucosa.

5 to any irregularities within the heterotopic mucosa.

6 ing effector T cell responses at the gastric mucosa.

7 osinophil peroxidase deposition in bronchial mucosa.

8 eased neutrophil accumulation at the gastric mucosa.

9 food antigens in contact with the esophageal mucosa.

10 s without the deleterious effects on stomach mucosa.

11 recurrent infections in the skin and genital mucosa.

12 ntranuclear staining and little virus at the mucosa.

13 ed the transcriptome of the small intestinal mucosa.

14 icipate in antiviral responses in intestinal mucosa.

15 entially presented corpus and/or cardia-type mucosa.

16 most basal crypt epithelial cells of normal mucosa.

17 ABO blood group antigen-glycosylated gastric mucosa.

18 immune (CMI) responses in the genital tract mucosa.

19 xpression and neutrophil infiltration in the mucosa.

20 s of endogenous Th17 cells in the intestinal mucosa.

21 IL-6 immunolabeling in the inflamed gingival mucosa.

22 tern of E-cadherin expression in the gastric mucosa.

23 C samples and adjacent uninvolved intestinal mucosa.

24 acidic/enzymatic environment of the gastric mucosa.

25 ia monocytogenes infection in the intestinal mucosa.

26 ms, focusing in particular on the intestinal mucosa.

27 was analyzed in normal human cells of colon mucosa.

28 ral to the maintenance of homeostasis in the mucosa.

29 r of 5-HT-containing EC cells in the colonic mucosa.

30 nd no responses were observed at the colonic mucosa.

31 o pressure pulses delivered to the olfactory mucosa.

32 mannosylated glycoproteins on the urothelial mucosa.

33 ases (MMPs) in cell lines and in the gastric mucosa.

34 biopsy specimens of the rectosigmoid colonic mucosa.

35 mple-type endings in the circular muscle and mucosa.

36 phery and with immune dysfunction in the gut mucosa.

37 ointing to its biological interaction in the mucosa.

38 Env-specific IgG binding titers in serum and mucosa.

39 en pro- and anti-inflammatory factors in the mucosa.

40 lymphangiogenesis in both the mesentery and mucosa.

41 s in their tissues, including the intestinal mucosa.

42 tion of inflammatory cells into the tracheal mucosa.

43 eighboring epithelial cells in the bronchial mucosa.

44 ts that actively circulate through the ileal mucosa.

45 and inflammatory mediators in the intestinal mucosa.

46 oth innate and adaptive immunity in the lung mucosa.

47 tation, as well as matched samples of normal mucosa.

48 , or RNA and protein were collected from the mucosa.

49 es of acetylcholine (ACh) within the gastric mucosa.

50 innate gamma/delta T17 cells in the colonic mucosa.

51 s, with cDC2 functioning as guardians of the mucosa.

52 osaicism in APC in non-neoplastic intestinal mucosa.

53 ion of inflammatory cells in the respiratory mucosa.

54 l mucosa (9.2%), and HPV-76 (beta-3) in anal mucosa (14.9%).

55 tological finding of non-transformed gastric mucosa, 20 patients with AG or IM (AG/IM GC-), and 18 pa

56 ocarcinoma (GC) and AG or IM in the adjacent mucosa (3 cm from the macroscopic tumour margin, AG/IM G

57 hairs (60.9%), oral mucosa (35.6%), and anal mucosa (33.3%).

58 rm skin (64.4%), eyebrow hairs (60.9%), oral mucosa (35.6%), and anal mucosa (33.3%).

59 an across the 2 mucosal sites (anal and oral mucosa, 6.9%).

60 V-12 (beta-1) in forearm skin (23%) and oral mucosa (9.2%), and HPV-76 (beta-3) in anal mucosa (14.9%

61 on the adaptation of lymphocytes to the gut mucosa, a highly specialized environment that can help u

62 HIV receptors resided in the female genital mucosa, a site where HIV-1 transmission occurs.

63 helial cell kinetics in AG and IM in gastric mucosa adjacent to gastric cancer is still unclear.

64 as well as in AG/IM GC- compared to AG/IM in mucosa adjacent to GC+ (p < 0.05).

65 0.0001) but not compared to AG/IM in gastric mucosa adjacent to GC.

66 ght adhesion of the whole system to the oral mucosa after application.

67 standardized allergens locally to the nasal mucosa allowing clinical symptoms and biospecimens such

68 s in precancerous conditions, i.e., atrophic mucosa (AM) and intestinal metaplasia (IM), in patients

69 tions stronger in Crohn's disease and in gut mucosa among associations stronger in ulcerative colitis

70 s and tissue-resident CD3 T cells in the gut mucosa and bone marrow.

71 s, an effect mediated by 5-HT in the colonic mucosa and by 5-HT3 receptors.

72 ls, which are located between the muscularis mucosa and circular muscular layer of the human gut.

73 ta to RNA-Seq from both the small intestinal mucosa and colonic mucosa of healthy control mice or tho

74 d therefore differentiate between effects on mucosa and digesta in the proximal, mid and the distal i

75 her strategies to treat diseases of the oral mucosa and digestive tract.

76 e tongue malignancy (82%) followed by buccal mucosa and gingivobuccal sulcus malignancy (18%).

77 l that commensals were present in the ocular mucosa and had functional immunological consequences.

78 cystitis (KIC) initially damaged the bladder mucosa and induced contracted bladder thereafter.

79 iarrheagenic pathogen that colonizes the gut mucosa and induces attaching-and-effacing lesions.

80 -UCRs that regulate growth of the intestinal mucosa and investigated the mechanism by which T-UCR uc.

81 cells (ILC2s) are effector cells within the mucosa and key participants in type 2 immune responses i

82 The distribution of SP and TLRs in the nasal mucosa and local airway neurons was assessed with immuno

83 erity of patients' symptoms, aspect of nasal mucosa and medical intake as parameters of CRS control.

84 e level and bacteria loads in the intestinal mucosa and peripheral organs were elevated in Lpa1(-/-)

85 uced H5N1 virus replication in the olfactory mucosa and prevented subsequent virus spread to the CNS.

86 and IL1alpha gene expression in the colonic mucosa and reduced the amounts of proinflammatory, cance

87 of how homeostasis is maintained within the mucosa and set the stage for development of novel therap

88 y signaling and cytoskeleton in human rectal mucosa and so influence cancer risk.

89 RNA that regulates growth of the intestinal mucosa and stimulates intestinal epithelial renewal by r

90 indle and epithelioid features involving the mucosa and submucosa (Fig 1A).

91 uter part of the muscular layer, whereas the mucosa and submucosa were normal.

92 nza A viruses can replicate in the olfactory mucosa and subsequently use the olfactory nerve to enter

93 g of the interactions between the intestinal mucosa and the enteric microbiota.

94 e another, notably at the border between the mucosa and the lumen.

95 (GUCY2C), a receptor expressed by intestinal mucosa and universally expressed by metastatic colorecta

96 PTEN, and TJP1 in colonic IBD as well as UC mucosa, and between inflammation and increased expressio

97 ia, and virus was isolated from tonsils, gut mucosa, and draining lymph nodes.

98 sed in proportion to CGVHD activity in skin, mucosa, and glands, and expression of TLR7 and DDX58 rec

99 rophic lesions affecting nails, glands, oral mucosa, and palmar-plantar epidermis.

100 ing human intestinal organoids (HIOs), colon mucosa, and retina.

101 The buccal mucosa appeared as an intermediate ecological niche betw

102 ypes of dendritic cells (DC) in the skin and mucosa are Langerhans cells (LC) and interstitial dermal

103 lial shedding and scarring of fallopian tube mucosa are the main consequences of sexually transmitted

104 h a type 2 immune response in the intestinal mucosa are up-regulated in treatment-naive pediatric pat

105 surfaces of the body, in particular the gut mucosa, are the major sites where immune cells traffic a

106 accumulation of immune cells in the duodenal mucosa as a consequence of both adaptive and innate immu

107 rment of neutrophil recruitment to the colon mucosa as a result of defective cytokine and chemokine p

108 is a pre-malignant condition of the gastric mucosa associated with increased gastric cancer (GC) ris

109 ze structural and metabolic changes in colon mucosa associated with WD and predisposition to colorect

110 ts in GALT hyperplasia and, in some animals, mucosa-associated B cell lymphoma.

111 Dietary supplementation with SUCRAM affected mucosa-associated bacterial community structure along th

112 gy shape the composition and activity of the mucosa-associated bacterial community.

113 ignificant differences in the composition of mucosa-associated compared with lumenal microbiota in pi

114 al sites, such as CD1-restricted T cells and mucosa-associated innate T cells, should be explored.

115 Mucosa-associated invariant T (MAIT) cells are a large i

116 a population of innate-like T cells, called mucosa-associated invariant T (MAIT) cells, as the most

117 ll lymphomas (DLBCLs), including DLBCLs with mucosa-associated lymphoid tissue (DLBCL[MALT]) and with

118 l marginal zone (MZ) B-cell lymphomas of the mucosa-associated lymphoid tissue (MALT) arise from lymp

119 yphlocolitis, associated epithelial defects, mucosa-associated lymphoid tissue (MALT) hyperplasia, an

120 While primary ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma (POAML

121 ulture who previously received rituximab for mucosa-associated lymphoid tissue (MALT) lymphoma and st

122 stopathology and immunohistochemistry showed mucosa-associated lymphoid tissue (MALT) lymphoma with i

123 ion resulted in the best OS in patients with mucosa-associated lymphoid tissue (MALT) lymphomas (HR =

124 utes can allow antigens to interact with the mucosa-associated lymphoid tissue (MALT) to induce both

125 ed were extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT).

126 ces for extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT).

127 nversion (RT-QuIC) assay by using recto-anal mucosa-associated lymphoid tissue (RAMALT) biopsy specim

128 plex with B-cell CLL/lymphoma 10 (BCL10) and mucosa-associated lymphoid tissue lymphoma translocation

129 Among cases of conjunctival mucosa-associated lymphoid tissue lymphoma, human herpes

130 lorambucil demonstrated superior efficacy in mucosa-associated lymphoid tissue lymphoma; however, imp

131 lymphomas (2.3%) were the most frequent, and mucosa-associated lymphoid tissue lymphomas (5.8%).

132 ts with extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue.

133 reased IgD CSR exclusively within B cells of mucosa-associated lymphoid tissues.

134 To identify mucosa-associated microbes, bacterial 16S rRNA and funga

135 Mucosa-associated microbial populations of the gastroint

136 ing Illumina sequencing we characterised the mucosa-associated microbiota along the length of the int

137 The composition of the colonic luminal and mucosa-associated microbiota differed between villin-TLR

138 study assessed the structure of the colonic mucosa-associated microbiota in mice exposed to a social

139 We collected information on the fecal and mucosa-associated microbiota of patients with IBS and ev

140 rthermore, the dominant member of this wound-mucosa-associated microbiota, Akkermansia muciniphila (a

141 r exposure significantly affects the colonic mucosa-associated microbiota, and exacerbates Citrobacte

142 us, alcohol appears to impair control of the mucosa-associated microbiota, and subsequent breach of t

143 ere clear distinctions in the composition of mucosa-associated microbiota, between small and large in

144 ined the effect of SUCRAM supplementation on mucosa-associated populations.

145 eby oral AM80 administration suppressed lung mucosa-associated Tfh and autoantibody responses by incr

146 ells, the ordered colonization of the serosa-mucosa axis by clonal descendants, and gut expansion.

147 xplants compared to explants from the buccal mucosa (BM), HP, and transition zone of the lower lip (T

148 ed MFSD2A not only localized to the inflamed mucosa but also restored the ability of the endothelium

149 a benign commensal yeast living on skin and mucosa, but poised to invade injured tissue to cause loc

150 ray on the afferent innervation of the nasal mucosa by monitoring trigeminal nerve activity in patien

151 testinal tract, with regard to human colonic mucosa cells cultured in vitro.

152 tein Cx43 were markedly diminished in buccal mucosa cells from arrhythmogenic cardiomyopathy patients

153 Buccal mucosa cells from arrhythmogenic cardiomyopathy patients

154 The intestinal mucosa comprises the inner lining of the intestinal trac

155 including a line derived from normal rectal mucosa (control) and an adenocarcinoma line derived from

156 ol biopsy samples of non-transformed gastric mucosa (Control).

157 the profile of the microbiota in the colonic mucosa could discriminate patients with constipation fro

158 d ST2 production was evaluated in intestinal mucosa cultures.

159 ated bladder hyperactivity, lessened bladder mucosa damage, and decreased interstitial fibrosis.

160 junctional complexes, mucus production, and mucosa-derived antimicrobials.

161 redness (MR), suppuration (SUP), keratinized mucosa dimension, and marginal bone loss.

162 The reconstruction includes mucosa distribution enabling a realistic simulation of t

163 y enteric glia, however, particularly in the mucosa, do not express GFAP.

164 human CD49d(+) PMNs are present in the nasal mucosa during acute viral respiratory tract infections a

165 ILC2s are recruited to the nasal mucosa during COX-1 inhibitor-induced reactions in patie

166 ers change in peripheral blood and the nasal mucosa during COX-1 inhibitor-induced reactions in patie

167 cells were markedly increased in the jejunal mucosa during primary infections with S. venezuelensis S

168 respectively, active vs placebo) and gastric mucosa eosinophils counts (239 eosinophils/mm(2) [59-645

169 stem appears appropriate for the use in oral mucosa, especially for sublingual and buccal tissues.

170 r routes, ZIKV replicates within the genital mucosa even in wild-type (WT) mice.

171 In PDSG and PDCimG, gingival mucosa exhibited few collagen fibers among numerous infl

172 The mammalian intestinal mucosa exhibits a spectrum of responses after acute inju

173 The airway mucosa expresses protective interferon (IFN) and inflamm

174 licobacter pylori can persist in the gastric mucosa for decades.

175 are routinely used worldwide to sample human mucosa for microbiological screening with culture method

176 porter 1 might be a target in the intestinal mucosa for treatment of secretory diarrheas.

177 Ex vivo cultures of ileal and colonic mucosa from 10 PI-IBS, diarrhea predominant subtype (D)

178 oglobulin repertoires of blood and the nasal mucosa from aeroallergen-sensitized subjects before and

179 RNA was expressed in human jejunum and mouse mucosa from all segments of the small bowel.

180 We used electron microscopy on esophageal mucosa from an affected family member carrying the gene

181 om proximal, mid and distal intestine and of mucosa from mid and distal intestine of 67.3 g salmon ke

182 high-resolution microendoscopy image of oral mucosa from one volunteer.

183 erves were significantly more superficial in mucosa from patients with NERD-both distal (median, 9.5

184 ood, the cellular response at the intestinal mucosa has never been directly assessed.

185 on the impact of HPDs on the large intestine mucosa homeostasis.

186 ion of the NLRP3 inflammasome in the bladder mucosa; however, the presence of TcpC in WT CFT073 reduc

187 oth T2-weighted MR imaging and Raman gastric mucosa imaging using functionalized MGNs.

188 ay colonization is known to alter the airway mucosa immune response in neonates whereas the impact of

189 owing that seeding scaffolds with autologous mucosa improves regeneration.

190 between a small number of cells of the nasal mucosa in >90% of animals from 5 to 60 min after inhalat

191 ers neoplastic transformation of the gastric mucosa in a small subset of patients, but the risk facto

192 ance of CD8(+) T cells in the nasopharyngeal mucosa in association with clearance of FMDV.

193 he severity of inflammation in human gastric mucosa in either a synchronous or metachronous manner.

194 n, and consequences for the large intestinal mucosa in humans.A randomized, double-blind, parallel-de

195 ce the interaction between odorants and oral mucosa in the oral cavity during a "wine intake-like" si

196 Our data suggest that lumen and mucosa in the proximal colon should be conceptualized no

197 -term systematic follow-up of the esophageal mucosa including multistaged biopsies is required, even

198 ues, but it also inhibited repair of damaged mucosa induced by mesenteric ischemia/reperfusion in the

199 CD8(+) T cells in the intestinal mucosa influence the HIV-associated pathogenesis, but li

200 time, the impact of wine composition on oral-mucosa interactions under physiological conditions.

201 Restitution of injured mucosa involves the recruitment of immune cells, epithel

202 The delivery of vaccines to the sublingual mucosa is an attractive prospect due to the ease and acc

203 ophageal prick test, in which the esophageal mucosa is challenged by local injection of allergen extr

204 ion model, PMN infiltration into the gastric mucosa is dramatically reduced in Coro1A(-/-) mice, resu

205 Compared to skin, wound healing in oral mucosa is faster and produces less scarring, but the mec

206 cosal biopsy used to characterize the airway mucosa is invasive, poorly tolerated, and does not allow

207 The endometrial mucosa is populated by a variety of immune cells which i

208 s esophagus segment and any visible columnar mucosa is suggested.

209 The mucosa is the primary point of entry for pathogens makin

210 major class of antibody secreted by the gut mucosa, is an important contributor to gut barrier funct

211 ubsequent crossing of epithelial barriers in mucosa-lined organs such as the lungs and intestines.

212 d on two data sets (human gastric and salmon mucosa O-linked glycomes) for which MS/MS spectra were a

213 ptase PCR in infected and uninfected gastric mucosa obtained from Bhutan and from the Dominican Repub

214 ple of locally induced immunoglobulin in the mucosa of a cold-blooded species.

215 ed mucosal immune responses within the nasal mucosa of a vertebrate species, a strategy that likely o

216 enterocolitica was present within the murine mucosa of both ileum and colon.

217 ly rescues the CF phenotype across the nasal mucosa of CF mice and in patient-derived organoids.

218 significantly between the distal esophageal mucosa of controls (median, 25.5 cell layers to surface;

219 differentially expressed between intestinal mucosa of fasted vs non-fasted mice.

220 both the small intestinal mucosa and colonic mucosa of healthy control mice or those exhibiting NSAID

221 ve species that colonizes the nares and anal mucosa of healthy dogs and cats.

222 n, can be used to deliver RNA to the colonic mucosa of living mice.

223 d to deliver mRNAs and siRNAs to the colonic mucosa of mice and knock down expression of target mRNAs

224 release and submucosal swelling in the nasal mucosa of mice that depends on cysLTs, as it is absent i

225 expression was amplified in bronchial/nasal mucosa of neutrophilic asthma prone to exacerbation, sug

226 r-beta, which is increased in the intestinal mucosa of patients with active Crohn's disease (CD).

227 tients with NERD, from the distal esophageal mucosa of patients with ERD, and the distal-most squamou

228 The intestinal mucosa of patients with inflammatory bowel diseases has

229 NMPs) were measured while exposing the nasal mucosa of patients with IR and HC subjects to aerosols w

230 Proximal and distal esophageal mucosa of patients with NERD have more superficial affer

231 ined from the proximal and distal esophageal mucosa of patients with NERD, from the distal esophageal

232 atrophic gastritis or intestinal metaplasia mucosa of patients without GC (AG/IM GC-) and in control

233 was significantly elevated in the bronchial mucosa of the asthmatic smokers compared to the non-smok

234 ls and eosinophils infiltrate the serosa and mucosa of the inflamed intestines.

235 cant only when short segments of cardia-type mucosa of the lower esophagus were included in the defin

236 ukocyte DNA and/or non-neoplastic intestinal mucosa of these patients.

237 trophil (PMN) infiltration of the intestinal mucosa often leads to severe epithelial injury; however,

238 were determined for lung and nasal olfactory mucosa (OM) from Cyp2abfgs-null, CYP2A13-humanized, and

239 The olfactory mucosa (OM) is exposed to environmental agents and there

240 in in cerebrospinal fluid (CSF) or olfactory mucosa (OM) samples.

241 al-associated lymphoid tissue, and olfactory mucosa (OM).

242 bulin response would be generated within its mucosa on microbial exposure.

243 ctic treatment to block HIV-1 penetration in mucosa or in chronically infected patients in combinatio

244 nasal polyp tissue but not the healthy nasal mucosa or periphery.

245 issues such as vessels, lymphocytes, nerves, mucosa, or stroma were more strongly labeled with the an

246 ncreased compared to not transformed gastric mucosa (p < 0.0001) but not compared to AG/IM in gastric

247 eal squamous cell cancer compared to control mucosa (p < 0.05); 2) CYSLTR1 and CYSLTR2 gene expressio

248 process specifically targets the intestinal mucosa, patients may present with gastrointestinal signs

249 a key modulatory roles in normal intestinal mucosa permeability and in inflammatory and hypoxic cond

250 Neither nasal passage nor mucosa positivity was determinant of later disease onset

251 y PP was confirmed in mouse descending colon mucosa preparations expressing native Y4R, demonstrating

252 In contrast, the gut mucosa presented an anergic cytokine profile in relation

253 While the sublingual (SL) mucosa presents several barriers to vaccine penetration,

254 memory T cells can readily home to the lung mucosa prior to and shortly after pathogen exposure.

255 immune responses as well as degrade the host mucosa, processes that ultimately increase susceptibilit

256 In mucosa, Proteobacteria dominated the microbiota (90%), w

257 WD increased colon tumor numbers, and mucosa proteomic analysis indicated severe deregulation

258 ction and host gene expression in the rectal mucosa, raising new questions on the impact of HPDs on t

259 unctional effects in the healthy large-bowel mucosa remain to be investigated.

260 ere processed as whole mounts (submucosa and mucosa removed) to examine CSMG efferent terminals.

261 innate-mediated inflammation in the vaginal mucosa rescues this phenotype and completely inhibits ZI

262 indings have revealed roles for systemic and mucosa-resident memory CD8(+) T cells in the orchestrati

263 Fibroblasts were obtained from nasal mucosa; samples of control subjects (NM-C, n = 8) and fr

264 onsil, mesentery lymph nodes, and intestinal mucosa served as major target sites of viral replication

265 In Ussing chambered mucosa-submucosa preparations (including the submucosal

266 key roles in homeostatic processes in rectal mucosa, such as cell cycle or cell death.This human inte

267 vent H5N1 virus replication in the olfactory mucosa sufficiently, resulting in CNS invasion via the o

268 ts proficiently colonized the murine gastric mucosa, suggesting that the amino acid composition-depen

269 tive actions of RvD3 and AT-RvD3 for injured mucosa that accelerated restoration of epithelial barrie

270 sponse from gammadelta T cells in the ocular mucosa that was central to local immunity.

271 ding the degree of enrichment within the gut mucosa, the activation status in blood, the type of TCRd

272 the pool of resident Mvarphis in the colonic mucosa, the homeostatic regulation of Mvarphi in the sma

273 heir low permeability through the intestinal mucosa, the released protein would be soon degraded by t

274 al's age, diverticulae, or herniation of the mucosa through the colonic wall, develop.

275 of MDSCs that predict a shift in the gastric mucosa to a metaplastic phenotype.

276 ort that villin is cleaved in the intestinal mucosa to generate a pro-apoptotic fragment that is spat

277 ous antigens and migrate out of the skin and mucosa to the draining lymph nodes to present antigens t

278 Intraepithelial dysplasia of the oral mucosa typically originates in the proliferative cell la

279 from OAC with 12 NDF from normal oesophageal mucosa using Infinium HumanMethylation450 Beadchips and

280 at clearance of FMDV from the nasopharyngeal mucosa was associated with upregulation of targets assoc

281 to the bone marrow as opposed to the rectal mucosa was linked to viral control.

282 Human intestinal mucosa was modeled using Caco-2 cells.

283 Neutrophil density in the bronchial mucosa was similar across health and the spectrum of ast

284 croinjection of PMN-MPs into wounded colonic mucosa was sufficient to impair epithelial wound healing

285 l peroxidase by eosinophils in the bronchial mucosa, was maintained after mepolizumab.

286 ncreased expression of PTPN22 in colonic IBD mucosa, was observed.

287 nd MMP-9-immunolabeled cells in the gingival mucosa were quantified.

288 normal-appearing, perilesional skin or oral mucosa when possible.

289 sports polymeric Abs across epithelia to the mucosa, where proteolytic cleavage releases the ectodoma

290 ed genes in gastric cancer (GC) and adjacent mucosa with atrophic gastritis or intestinal metaplasia

291 differentiated dysplasia from control/benign mucosa with higher sensitivity and specificity than basa

292 llular three-dimensional model of human oral mucosa with induced inflammation promoted MMP12 producti

293 cobacter pylori (H. pylori)-infected gastric mucosa with intestinal metaplasia (IM) changes.

294 that these viruses replicate in the vaginal mucosa with minimal induction of antiviral interferon an

295 a unique opportunity to study ECTI in intact mucosa with simultaneous assessment of cellular and extr

296 pH1N1 (P0) virus was restricted to the nasal mucosa, with no virus detected in the trachea or lungs.

297 D14(+) monocytes were recruited to the nasal mucosa within hours after local allergen challenge, wher

298 illous trophoblasts (EVT) invade the uterine mucosa without being rejected by the maternal immune sys

299 s rapid tumour clearance from the intestinal mucosa without effects on normal intestinal crypts.

300 providing stabilized access to the tracheal mucosa without intubation, our setup uniquely allows dyn